Furiex Pharmaceuticals Inc - Morrisville, North Carolina 27560

Furiex Pharmaceuticals Inc is categorized under Research and Development Laboratories in Morrisville, NC .

Business Name: Furiex Pharmaceuticals Inc
Contact Person: June Almenoff, President
Address: 3900 Paramount Parkway # 150, Morrisville, North Carolina 27560
Phone Number: (919) 456-7800
Website Address: furiex.com
Annual Revenue (USD): Unknown
Founding Year: 1998
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 3254120
Share This Business:
Related Businesses: Ppd Development - Morrisville, NC 27560
Bayer Cropscience - Morrisville, NC 27560
Worldwide Clinical Trials - Morrisville, NC 27560
Siobhan Sneed - Morrisville, NC 27560
Ini Power Systems - Morrisville, NC 27560
Liquidia Technologies Inc - Morrisville, NC 27560
Ppd Development Lp - Morrisville, NC 27560
Synthon Pharmaceuticals - Morrisville, NC 27560
Liquidia Tech - Morrisville, NC 27560
Gravely Research Corporation - Morrisville, NC 27560
Rrc-Sgte Technologies LLC - Morrisville, NC 27560
Quintiles - Morrisville, NC 27560
Qualyst - Morrisville, NC 27560

The company Furiex Pharmaceuticals Inc provides B2B services in the form of Research and Development Laboratories from its headquarters in North Carolina. 1 to 4 employees work for Furiex Pharmaceuticals Inc, and the business now earns Unknown per annum.

Furiex Pharmaceuticals Inc was launched in 1998 and is classified under SIC code and category 8731 , and NAICS number and grouping 3254120 . To contact Furiex Pharmaceuticals Inc, please call June Almenoff, President with the phone number (919) 456-7800 or visit its headquarters at 3900 Paramount Parkway # 150 in Morrisville, North Carolina 27560.

The location of the headquarters can also be found using the coordinates 35.85581,-78.83017. Read more details about this business on the webpage furiex.com or follow the company’s social media accounts, on Twitter and on Facebook.